Who owns the NEW TELLY trademark?

The NEW TELLY trademark is owned by Zhuhai Trinomab Pharmaceutical Co., Ltd..

What is the serial number for NEW TELLY?

The USPTO serial number for NEW TELLY is 79354573.

What is the registration number for NEW TELLY?

NEW TELLY is registered under USPTO registration number 7691092.

NEW

USPTO Trademark Record

REGISTERED

NEW TELLY

Q: What class is the NEW TELLY trademark registered in?

The NEW TELLY trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services).

SN 79354573·Reg 7691092·Filed Sep 07, 2022

Owner Zhuhai Trinomab Pharmaceutical Co., Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Advertising; business management, organization and administration; office functions.

NEW TELLY (Serial No. 79354573), Registration No. 7691092, is a registered US trademark filed on Sep 07, 2022 by Zhuhai Trinomab Pharmaceutical Co., Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 035 (Advertising, business management & retail services).

early section 8: February 18, 2031

Mark Intelligence

NEW TELLY (Reg. #7691092) is a registered US trademark that has been protecting its owner, Zhuhai Trinomab Pharmaceutical Co., Ltd., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 035 (Advertising, business management & retail services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

Sep 07, 2022

SERIAL

79354573

REG#

7691092

REGISTERED

Feb 18, 2025

Owner

Applicant

Zhuhai Trinomab Pharmaceutical Co., Ltd.

Entity

Not Provided

Address

Rm.110, 1/F., Plant Building 6,, No.6366 Zhuhai Avenue, Jinwan District, Zhuhai City, Guangdong

Country

Attorney

Law firm

Beyond Attorneys at Law

Address

Rm. 606, F6, Xijin Centre,, 39 Lianhuachi East Rd.,, 100036 Beijing, , CHINA

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 07, 2022

Serial Number79354573

Registration No.7691092

Registration DateFeb 18, 2025

Status DateFeb 18, 2025

Published for OppositionDec 31, 2024

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 4× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

20 events

NOTIFICATION PROCESSED BY IB

Oct 10, 2025

NOTIFICATION PROCESSED BY IB

IRREGULARITY FROM IB EXAMINED BY MPU

Sep 12, 2025

IRREGULARITY FROM IB EXAMINED BY MPU

IRREGULARITY ON FINAL DECISION RECEIVED FROM IB

Aug 27, 2025

IRREGULARITY ON FINAL DECISION RECEIVED FROM IB

FINAL DISPOSITION PROCESSED

Aug 14, 2025

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Aug 14, 2025

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

May 18, 2025

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Feb 18, 2025

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Dec 31, 2024

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Dec 25, 2024

NOTICE OF PUBLICATION

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 09, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Apr 29, 2024

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Apr 10, 2024

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 10, 2024

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

CHANGE OF NAME/ADDRESS REC'D FROM IB

Sep 22, 2023

CHANGE OF NAME/ADDRESS REC'D FROM IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

May 04, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

May 03, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Apr 26, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Nov 18, 2022

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 14, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Nov 10, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

NEW TELLY

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Zhuhai Trinomab Pharmaceutical Co., Ltd.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Resources

Company